Herpes Simplex Virus Flashcards

1
Q

What are the seroprevalence rates of HSV-1 and HSV-2 among persons aged 14 to 49 years in the United States?

A

HSV-1: 47.8%, HSV-2: 11.9%

These rates indicate the prevalence of these viruses in a significant age group.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the primary cause of recurrent genital herpes?

A

HSV-2

Although HSV-1 is increasingly causing first-episode genital herpes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What percentage of first-episode genital herpes is caused by HSV-1 in certain populations?

A

Up to 70%

Particularly noted in young adult women and men who have sex with men.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the relationship between HSV-2 infection and HIV acquisition risk?

A

Increases the risk two- to three-fold

This is due to the immunocompromised state associated with HSV-2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the classic manifestations of oral HSV-1 infection?

A

Sensory prodrome, lesions on lips and oral mucosa evolving from papule to vesicle, ulcer, and crust

The course of illness lasts 5 to 10 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the typical local symptoms associated with genital herpes?

A

Sensory prodrome, pain, pruritus, dysuria, and vaginal or urethral discharge

Inguinal lymphadenopathy is also common, especially in primary infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or False: Genital HSV-1 infections typically have more recurrences than genital HSV-2 infections.

A

False

Recurrences and viral shedding occur less often with genital HSV-1 infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the preferred laboratory method for diagnosing mucocutaneous HSV infections?

A

HSV DNA polymerase chain reaction (PCR)

PCR is the most sensitive method for diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should be considered when counseling a patient diagnosed with HSV-2?

A

Risk of transmitting infection to sex partners

Counseling guidelines are provided in CDC STD Treatment Guidelines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fill in the blank: Consistent use of _______ reduces HSV-2 acquisition among heterosexual couples.

A

latex condoms

This is important for preventing transmission of HSV-2 and other STIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What antiviral therapy can reduce HSV-2 transmission to susceptible partners by 48%?

A

Suppressive antiviral therapy (e.g., valacyclovir 500 mg once daily)

This applies to HSV-2 seropositive persons with symptomatic genital herpes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the recommended treatment duration for first episodes of genital HSV?

A

7 days to 10 days

Recurrences can be treated for 5 to 10 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the treatment of choice for acyclovir-resistant HSV?

A

IV foscarnet

IV cidofovir is a potential alternative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the effect of suppressive therapy with antiviral drugs on HIV progression?

A

Does not delay HIV progression

Antiviral regimens for herpes should not replace ART.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the risk associated with HSV acquisition late in pregnancy?

A

Higher risk of neonatal HSV transmission

This is particularly a concern for HSV-2-seropositive pregnant women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

True or False: Acyclovir is considered safe for use during pregnancy, especially in the second and third trimesters.

A

True

It has the most reported experience in pregnancy.

17
Q

What should be monitored in patients receiving high-dose IV acyclovir?

A

Renal function

Monitoring should be done at initiation and once or twice weekly during treatment.

18
Q

What is the primary concern with HSV during pregnancy?

A

Potential for transmission to the fetus or neonate

This can have serious consequences, including fatal outcomes.

19
Q

What does suppressive therapy with oral acyclovir, valacyclovir, or famciclovir effectively prevent?

A

Recurrences of HSV lesions

It is particularly preferred for patients with severe or frequent recurrences.

20
Q

What antiviral drugs are mentioned as safe and well tolerated during pregnancy?

A

Valacyclovir and famciclovir

These drugs are particularly noted for their use in the third trimester.

21
Q

What is the predominant risk factor for neonatal HSV transmission during delivery?

A

Maternal genital shedding of HSV at delivery

This is a critical factor in the potential transmission of HSV to the neonate.

22
Q

When is cesarean delivery recommended for women with genital herpes?

A

When there is a genital herpes prodrome or visible HSV genital lesions at the onset of labor

This recommendation aims to reduce the risk of neonatal HSV transmission.

23
Q

What is the recommended suppressive therapy for pregnant women with recurrences of genital herpes?

A

Suppressive therapy with either valacyclovir or acyclovir starting at 36 weeks’ gestation

This is recommended for managing recurrences during pregnancy.

24
Q

What is the dosing regimen for treating orolabial lesions?

A

Valacyclovir 1 g PO twice a day, Famciclovir 500 mg PO twice a day, or Acyclovir 400 mg PO three times a day

Duration of treatment is 5–10 days.

25
Q

What is the treatment duration for initial genital lesions?

A

7–10 Days

This is the recommended duration for initial genital lesions.

26
Q

What constitutes chronic suppressive therapy for HSV?

A

Valacyclovir 500 mg PO twice a day, Famciclovir 500 mg PO twice a day, or Acyclovir 400 mg PO twice a day

This is for patients with severe recurrences or those who wish to minimize recurrence frequency.

27
Q

What is the preferred therapy for acyclovir-resistant mucocutaneous HSV infections?

A

IV Foscarnet 80–120 mg/kg/day in 2–3 divided doses until clinical response

This therapy is recommended for managing resistant infections.

28
Q

Fill in the blank: Suppressive therapy is not recommended for women who are seropositive for HSV-2 but have _______.

A

no history of genital lesions

29
Q

True or False: Neonatal HSV disease has been reported in infants born to women treated with antenatal suppressive antiviral therapy.

A

True

This indicates that while therapy is beneficial, it may not eliminate all risks.

30
Q

What is the treatment for severe mucocutaneous HSV infections?

A

Acyclovir 5 mg/kg IV every 8 hours, then switch to oral therapy as lesions regress

Continue treatment until lesions have completely healed.

31
Q

How often should the need for suppressive therapy be evaluated?

A

Annually

Regular evaluation helps determine ongoing necessity.

32
Q

What is the alternative therapy for acyclovir-resistant mucocutaneous HSV infections?

A

IV cidofovir 5 mg/kg once weekly or topical formulations

Topical formulations include trifluridine, cidofovir, imiquimod, and foscarnet.